PLECANATIDE
| Brand name | TRULANCE |
|---|---|
| Active ingredient | PLECANATIDE |
| Strength | 3MG |
| Dosage form | TABLET |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | January 2017 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 11834521 | June 2034 | product |
| 12146003 | June 2034 | product |
| 11142549 | June 2034 | product |
| 10011637 | June 2034 | substance |
| 9616097 | August 2032 | product |
| 11319346 | March 2032 | product |
| 9925231 | September 2031 | product |
| 9610321 | September 2031 | use U-2230 |
| 9919024 | September 2031 | use U-1999 |
| 7041786 | January 2028 | substance |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.